BOC Ophthalmic Instruments managing director TONY COSENTINO explains why he operates his distribution business on the knowledge that customers will ultimately remember him for the service, not the sale.
An Aussie orthoptist working in global public health
STUART KEEL became interested in public health while witnessing stark eye health inequalities as part of the first national eye health survey. The experience has taken his career to the headquarters of the WHO. Read more
Change agents: educating parents about myopia
Research estimates myopia will affect 50% of the world by 2050, and recent COVID lockdowns appear to have only worsened the situation. As more patients – and their parents – seek effective interventions, practitioners should prepare to meet this oncoming public health demand. Read more
A pivotal opportunity to transform Australia’s eye health
One of the most important presentations at this year’s 52nd RANZCO Congress was the launch of the college’s Vision 2030 and Beyond plan to overcome Australia’s long-standing and complex eye health equity issues. Read more
Retinal imaging with confidence
A market-leading retinal imaging device was the final instrument Western Australian optometrist ADRIAN ROSSITER needed to modernise his equipment suite. He discusses using the device in an optometry setting. Read more
Accelerating treatments for IRDs – A/Prof Fred Chen
Researchers, including myself, at Lions Eye Institute (LEI) are developing treatments for genetic eye diseases, including gene replacement therapies for Usher syndrome and novel drugs for retinitis pigmentosa (RP) and Stargardt disease. Read more
Turning our attention to age-related macular degeneration – Specsavers
As part of Macula Month, DR JOSEPH PAUL, head of professional services at Specsavers, reveals data and insights on macular degeneration and discusses the organisation’s long-term plans to improve vision and health outcomes for patients with the condition. Read more
Understanding new treatment protocols for severe dry eye
At the completion of this CPD activity, optometrists will have developed their knowledge of treatment options for severe dry eye disease. Including:
- Understand the use of anti-inflammatory agents in the treatment of extreme dry eye
- Understand the benefits and contraindications for treatment of dry eye with topical ciclosporin and lifitegrast
- Understand the benefits, indications and contraindications of amniotic membrane therapy for dry eye
NOTE: Optomery Australia members can enter their details at the bottom of this article to have it automatically added to their Learning Plan. Read more
Lessons from a glaucoma management clinic
At the completion of this CPD activity, optometrists will have developed their knowledge of glaucoma management. Including:
- Understand the structural and functional indices that play a role in the monitoring of glaucoma
- Inform their own glaucoma-management plan based on assessment techniques and workflow used at the CFEH’s Glaucoma Management Clinic
- Recognise some uncommon differential diagnoses for patients presenting with glaucoma-like clinical features
- Review an example of a collaborative approach to the diagnosis and management of a patient presenting with potentially glaucomatous clinical features
NOTE: Optomery Australia members can enter their details at the bottom of this article to have it automatically added to their Learning Plan.
Sooner or later? The sequential bilateral cataract surgery debate
Sequential bilateral cataract surgery has been in the spotlight in recent months, prompting discussion around the risks and benefits of immediate versus delayed surgery. Insight explores both sides of the argument.